Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity.
about
Mesothelin-Targeted CARs: Driving T Cells to Solid TumorsCAR T cells for solid tumors: armed and ready to go?Boolean immunotherapy: reversal of fortune.Biology and clinical application of CAR T cells for B cell malignanciesAn NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities.Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell TherapyNew Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target MalignanciesA Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors.Driving CAR-based T-cell therapy to success.Enhancing the efficacy of adoptive cellular therapy by targeting tumor-induced immunosuppression.Out of the bitter came forth sweet: Activating CD28-dependent co-stimulation via PD-1 ligands.Immunotherapy for advanced melanoma: future directions.Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma.The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.Targeting Immune Checkpoints in Hematologic Malignancies.Increasing the safety and efficacy of chimeric antigen receptor T cell therapy.The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.Cell tracking using gold nanoparticles and computed tomography imaging.Chimeric switch receptor: switching for improved adoptive T-cell therapy against cancers.Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.Current state and future prospects of immunotherapy for glioma.A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies.Not All Immune Checkpoints Are Created Equal
P2860
Q26778759-719C060D-7AC8-474C-B327-DB8D516EF4DCQ26825489-62EB913A-5C2F-4F7F-95C4-0928DCF2078FQ33724290-A6BC649A-928C-4B4E-9381-F7D89EBBF0DAQ33907565-2295F449-AF1F-4884-AF72-AB36C5BB50D5Q34786615-333B41C2-690F-4753-8E68-5A106FCB132BQ36173500-FBD961CD-B6D7-4D6A-8F8C-E91FF2A96C7AQ36558375-BE0DACA8-D5F7-4383-BFBC-77E5310482ACQ36709308-8CE35851-1BBF-4E25-B3F0-FBC1013C6594Q37715684-8BEF9013-CE1C-4296-9FBE-062FE12B0A9DQ38525024-E1821AFC-B4F7-47F8-9FFC-DA1A1B1C5092Q38627207-26A7E415-AF9D-44B1-9584-B68D89D4C1C8Q38711163-C5C45A91-4F08-4216-BD50-AE4EA7C4BFAEQ38758789-5157FAF6-9998-4036-966F-7D2A4F0CD451Q38775177-AE5A15B2-3E8F-4E16-80CB-1A3788BF6DF7Q38963420-3F436908-6354-48F8-92A8-281C28914684Q39256918-EEADCAAD-D266-4CCD-82DA-313DF7A9A87CQ39294814-65A57B06-5BB2-4C09-8399-B9722D4B2CD3Q39330086-ACC6D319-3280-4DAA-B5DF-333605356EE0Q47812178-F735409A-B42C-47B5-A0A2-AE77277C4F58Q48188242-A67FC4F5-CE67-462B-B03F-9DA1496737D9Q50109459-28CFB0A0-2F43-4549-9E5A-908D09AFAD9AQ55287219-BA334C49-D5A5-4633-904E-20D9C7607D3EQ56889626-4CEE11A7-0CC7-44C2-B041-75EE1ADA6103
P2860
Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Human T cells engineered to ex ...... y enhanced antitumor activity.
@en
Human T cells engineered to ex ...... y enhanced antitumor activity.
@nl
type
label
Human T cells engineered to ex ...... y enhanced antitumor activity.
@en
Human T cells engineered to ex ...... y enhanced antitumor activity.
@nl
prefLabel
Human T cells engineered to ex ...... y enhanced antitumor activity.
@en
Human T cells engineered to ex ...... y enhanced antitumor activity.
@nl
P2093
P356
P1476
Human T cells engineered to ex ...... ay enhanced antitumor activity
@en
P2093
Chen Ankri
Katerina Shamalov
Miryam Horovitz-Fried
Shmuel Mauer
P304
P356
10.4049/JIMMUNOL.1203085
P407
P50
P577
2013-09-11T00:00:00Z